Bibliografía del artículo
1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1998-2000. JAMA 2003; 290:199-206.
2. Chronic hypertension in pregnancy. ACOG Practice Bulletin N-329. Obstet Gynecol 2001; 98:177-85.
3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.
4. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in pregnancy. Am J Obstet Gynecol 2000; 183:s1-22.
5. Vigil De Gracia P, Montufar Rueda C, Smith A. Pregnancy and severe chronic hypertension: maternal outcome. Hypertens Pregnancy 2004; 23:285-93.
6. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103:219-24.
7. Sibai BM, Mabie WC, Shamsa F, Villar MA, Anderson GD. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am Obstet Gynecol 1990; 162:960-6.
8. Sibai BM, Abdela TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61:571-6.
9. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in pregnancy. Am J Obstet Gynecol 2000; 183:s1-22.
10. Sibai MB, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruption placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998; 339:667-71.
11. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994; 171:410-6.
12. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996; 103:123-9.
13. Sibai BM, Anderson GD. Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstet Gynecol 1986; 67:517-22.
14. Vanek M, Sheiner E, Levy A, Mazor M. Cic hypertension and the risk for adeverse pregnancy outcome after superimposed pre-eclampsia. Inter J Gynecol Obstet 2004; 86:7-11.
15. Ferrer RL, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000; 96:849-860.
16. Vigil De Gracia P, Lasso M. Montufar Rueda C. Perinatal outcome in women with severe chronic hypertension during the second half of pregnancy. Int J Gynecol Obstet 2004; 85:139-44.
17. Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol 1984; 150:831-5.
18. Smith P, Anthony J, Johanson R. Nifedipine in pregnancy. Br J Obstet Gynecol 2000; 107:299-307.
19. Magee LA, Cham C, Waterman EJ, Ohlsson A, Von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327:955-60.
20. Vigil De Gracia P, Lasso M, Ruiz E, Vega Maleck JC, De Mena FT, López JC. Severe hypertension in pregnancy: Hydralazine or labetalol A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2006 (In press).
21. Cooper WO, Hernández Díaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354:2443-51.
22. Haddad B, Sibai BM. Chronic hypertension in pregnancy. Ann Med 1999; 31:246-52.
23. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002; 100:369-77.